Bowman and Brooke

Topics

Expert Analysis (15)

1. May 8, 2012 Mission Impossible: Impossibility Preemption Post-Levine
2. November 29, 2011 The Changing Scope Of Expert Witness Disclosures
3. September 21, 2011 The 5 'PRs' Of Product Preservation
4. August 30, 2011 Out-Of-State Witnesses Need Not Travel To Calif.
5. August 15, 2011 Fishing The Social Media Seas
6. June 10, 2011 Negotiated Rate Differential Meets Collateral Source Rule
7. November 24, 2010 The Potential Impact Of 'Recall Fatigue'
8. November 5, 2010 Nanoparticles: A New Mass Tort Frontier
9. October 8, 2010 A Special Rule For Corporate Exec Depositions
10. July 8, 2010 8 Steps To Reducing Nanotorts In Your Nanofuture
11. March 4, 2010 Evolving With Affirmative Defense Pleading Standard
12. January 11, 2010 The Impact Of 2009 Amendments To Rule 15
13. December 7, 2009 Combating Abusive Pleading With Iqbal/Twombly
14. March 17, 2009 Health Care Nanoscience: Regulation By Litigation
15. July 30, 2008 Riegel V. Medtronic: Better Off Without It?